truvada
Selected indexed studies
- Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. (N Engl J Med, 2024) [PMID:39046157]
- Emtricitabine/tenofovir (Truvada) for HIV prophylaxis. (Am Fam Physician, 2013) [PMID:24364575]
- Truvada intolerance. (AIDS, 2007) [PMID:17255751]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. (2024) pubmed
- Emtricitabine/tenofovir (Truvada) for HIV prophylaxis. (2013) pubmed
- Truvada intolerance. (2007) pubmed
- In brief: Truvada for HIV prevention. (2012) pubmed
- Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy. (2024) pubmed
- The Truvada wars. (2014) pubmed
- Effect of Truvada lawsuit advertising on preexposure prophylaxis attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV. (2021) pubmed
- PrEP, Truvada, and Gilead. (2016) pubmed
- How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores". (2015) pubmed
- HIV pre-exposure prophylaxis. (2012) pubmed